
News|Articles|April 2, 2003
- Pharmaceutical Technology-04-02-2003
- Volume 27
- Issue 4
Overhauling Compliance and GMPs
Author(s)Jill Wechsler
FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.
Advertisement
Articles in this issue
almost 23 years ago
Outsourcing Outlookalmost 23 years ago
April 2003almost 23 years ago
Identification of Out-of-Trend Stability ResultsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shaping the Future of Microbial Development: From Gene to GMP
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Women in STEM: Inspiration from Innovators in Pharma
4
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
5




